Becton, Dickinson and Co. news

   Watch this stock
Showing stories 1 - 10 of about 58   

Articles published

BDX 143.49 +0.09 (0.06%)
price chart
Monona biotech firm BD set to close by March 2014
A longtime Monona biotechnology company is slated to close - but not for nearly two years. BD, or Becton, Dickinson and Co., told employees last week the plant, at 2801 Industrial Drive, will close by March 2014 and its operations will be consolidated ...
Related articles »  
PEPFAR Launches Labs For Life with Partners
The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), led by the Office of the Global AIDS Coordinator in the U.S. Department of State, and Becton, Dickinson and Company (BD), a leading global medical technology company, today announced ...
Related articles »  
Becton to Buy Safety Syringes - Analyst Blog
recently announced a definitive deal to buy California-based health care company Safety Syringes, Inc. The financial details of the deal were not revealed by the company. The acquisition is expected to complete by the end of Becton Dickinson's fiscal ...
Related articles »  
New, Fully Automated BD MAX� MRSA Assay Rapidly Identifies Patients ...
BALTIMORE, July 9, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it received FDA clearance to market the BD MAX� MRSA molecular test in the United States.
Related articles »  
New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining ...
BALTIMORE, July 17, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), today announced that it obtained 510(k) clearance from the U.S.
Related articles »  
PEPFAR Announces $5 Million for Together for Girls Partnership
Launched in 2009, the partnership brings together private sector organizations, including the Nduna Foundation, Becton, Dickinson and Company, the CDC Foundation, and Grupo ABC; five United Nations agencies, including UNICEF, UNAIDS, UNFPA, UN ...
Related articles »  
Chugai earmarks $150M for antibody research in Singapore
Japan's Chugai Pharmaceutical is investing more than $150 million over 5 years to investigate antibodies at a new research facility in Singapore.
Related articles »  
Retractable Technologies, Inc. Launches New VanishPoint� Blood Collection Set
... our ability to continue to finance research and development as well as operations and expansion of production; the increased interest of larger market players, specifically Becton, Dickinson and Company, in providing devices to the safety market ...
Related articles »  
Great Basin Corporation Launches U.S. and Global Sales Efforts
SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Corporation, a privately-held molecular diagnostics company developing sample-to-result solutions, announced today it has hired Ron Rohrer and Rhonda Saxton as regional business directors to carry out the ...
Related articles »  
Implied Stock-Price Moves for U.S. Companies Reporting Results
... 6.80 13.80 8.06 08/02 BDX* BECTON DICKINSON 2.83 2.91 3.54 2.70 08/02 Aft-mkt ZAGG ZAGG INC 4.91 5.38 11.58 1.30 08/02 Bef-mkt CLX* CLOROX CO 2.12 2.41 3.08 2.25 08/02 Bef-mkt WNR WESTERN REFINING 5.52 6.27 8.80 2.05 08/02 Bef-mkt ...